Document Type : Original Article


1 Department of Parasitology and Mycology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

2 Department of Parasitology, Laboratory Science Research Center, Faculty of Paramedical, Golestan University of Medical Sciences, Gorgan, Iran

3 Kalaleh Health Center, Golestan University of Medical Sciences, Gorgan, Iran


Background and aims: Cutaneous leishmaniasis is a major health issue in many parts of Iran. Diagnosis of cutaneous leishmaniasis in a non-endemic area is not as simple as that in endemic foci. The management and treatment of this disease are global dilemmas. The purpose of this study was to identify Leishmania species isolated from human cutaneous leishmaniasis lesions in patients referred to health centers of Golestan province, Iran. 
Methods: Cutaneous leishmaniasis patients with suspected lesions were clinically examined. History of journey to the endemic areas of zoonotic cutaneous leishmaniasis and/or anthroponotic cutaneous leishmaniasis and the characteristics of their lesion(s) were recorded. Diagnosis of the lesion was done by using direct smear microscopy and conventional polymerase chain reaction. 
Results: Out of 360 patients, 202 (57.4 %) were male and 158 (42.8 %) were female. A total of 360 samples were selected from different cities. The number of infected samples in the cities is as follows: Azad Shahr [3 (1.5%)], Aq Qala [11 (5.7%)], Ali Abad [4 (2.1%)], Bandar Turkmen [3 (1.5%)], Bandar Gaz [2 (1%)], Ramian [3 (1.5%)], Kalaleh [23 (12.1%)], Kord koy [1 (0.5%)], Galikesh [7 (3.7 %)], Gomishan [12 (3.6 %)], Gorgan [13 (6.8 %)], Gonbad Qabus [99 (52.1 %)], Marave Tappe [7 (3.6%)] and Minoodasht [2 (1%)]. In the molecular investigations, 186 (96.8%) samples were observed to acquire rural cutaneous leishmaniasis, 4 (2.1%) to acquire urban cutaneous leishmaniasis and 170 (47.2%) to be uninfected. 
Conclusion: Although history of visiting endemic areas is an important factor to be considered in diagnosis, parasitological confirmation is necessary for the initiation of treatment.


Main Subjects

1.Mirzaei F, Bafghi AF, Mohaghegh MA, Jaliani HZ, Faridnia R, Kalani H. In vitro anti-leishmanial activity of Satureja hortensis and Artemisia dracunculus extracts on Leishmania major promastigotes. J Parasit Dis. 2016;40(4):1571-4. doi: 10.1007/ s12639-015-0730-9. 
2.Hajjaran H, Vasigheh F, Mohebali M, Rezaei S, Mamishi S, Charedar S. Direct diagnosis of Leishmania species on serosity materials punctured from cutaneous leishmaniasis patients using PCR-RFLP. J Clin Lab Anal. 2011;25(1):20-4. doi: 10.1002/jcla.20377. 
3.Mirzaie F, Eslami G, Yosefi MH, Pestehchian N. Molecular identification of Leishmania isolates obtained from patients suspected as having cutaneous leishmaniasis referred to reference laboratories from Yazd province in central Iran. Adv Biomed Res. 2013;2:92. doi: 10.4103/2277-9175.122525. 
4.Nemati S, Fazaeli A, Hajjaran H, Khamesipour A, Anbaran MF, Bozorgomid A, et al. Genetic diversity and phylogenetic analysis of the Iranian Leishmania parasites based on HSP70 gene PCR-RFLP and sequence analysis. Korean J Parasitol. 2017;55(4):367-74. doi: 10.3347/kjp.2017.55.4.367. 
5.Edrisiyan GH. Visceral Leishmaniasis in Iran and the role of serological tests in the diagnosis and epidemiological studies. Journal of Kerman University of Medical Sciences. 1996;3(2):97-108. 
6.Khatami A, Firooz A, Gorouhi F, Dowlati Y. Systematic review of New World cutaneous leishmaniasis: several points. Int J Dermatol. 2009;48(2):201; author reply -2. doi: 10.1111/j.1365-4632.2009.03971.x. 
7.Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7(5):e35671. doi: 10.1371/ journal.pone.0035671. 
8.Yaghoobi-Ershadi MR, Hanafi-Bojd AA, Javadian E, Jafari R, Zahraei-Ramazani AR, Mohebali M. A new focus of cutaneous leishmaniasis caused by Leishmania tropica. Saudi Med J. 2002;23(3):291-4. 
9.Tashakori M, Kuhls K, Al-Jawabreh A, Mauricio IL, Schonian G, Farajnia S, et al. Leishmania major: genetic heterogeneity of Iranian isolates by single-strand conformation polymorphism and sequence analysis of ribosomal DNA internal transcribed spacer. Acta Trop. 2006;98(1):52-8. doi: 10.1016/j. actatropica.2006.01.010. 
10.Tesh RB, Modi GB. A simple method for experimental infection of phlebotomine sand flies with Leishmania. Am J Trop Med Hyg. 1984;33(1):41-6. 
11.Lachaud L, Marchergui-Hammami S, Chabbert E, Dereure J, Dedet JP, Bastien P. Comparison of six PCR methods using peripheral blood for detection of canine visceral leishmaniasis. J Clin Microbiol. 2002;40(1):210-5.
12.Spotin A, Rouhani S, Ghaemmaghami P, Haghighi A, Zolfaghari MR, Amirkhani A, et al. Different morphologies of Leishmania major amastigotes with no molecular diversity in a neglected endemic area of zoonotic cutaneous leishmaniasis in Iran. Iran Biomed J. 2015;19(3):149-59. 
13.Monroy-Ostria A, Nasereddin A, Monteon VM, GuzmanBracho C, Jaffe CL. ITS1 PCR-RFLP diagnosis and characterization of Leishmania in clinical samples and strains from cases of human cutaneous leishmaniasis in states of the Mexican Southeast. Interdiscip Perspect Infect Dis. 2014;2014:607287. doi: 10.1155/2014/607287. 
14.Rotureau B. Ecology of the leishmania species in the Guianan ecoregion complex. Am J Trop Med Hyg. 2006;74(1):81-96. 
15.Schonian G, Nasereddin A, Dinse N, Schweynoch C, Schallig HD, Presber W, et al. PCR diagnosis and characterization of Leishmania in local and imported clinical samples. Diagn Microbiol Infect Dis. 2003;47(1):349-58. 
16.Yehia L, Adib-Houreih M, Raslan WF, Kibbi AG, Loya A, Firooz A, et al. Molecular diagnosis of cutaneous leishmaniasis and species identification: analysis of 122 biopsies with varied parasite index. J Cutan Pathol. 2012;39(3):347-55. doi: 10.1111/j.1600-0560.2011.01861.x. 
17.Ghasemloo H, Rasti S, Delavari M, Doroodgar A. Molecular Diagnosis of Clinical Isolates of Cutaneous Leishmaniasis Using ITS1 and KDNA Genes and Genetic Polymorphism of Leishmania in Kashan, Iran. Pak J Biol Sci. 2016;19(3):136-42. doi: 10.3923/pjbs.2016.136.142. 
18.Karamian M, Kuhls K, Hemmati M, Ghatee MA. Phylogenetic structure of Leishmania tropica in the new endemic focus Birjand in East Iran in comparison to other Iranian endemic regions. Acta Trop. 2016;158:68-76. doi: 10.1016/j. actatropica.2016.02.010.
19.Roelfsema JH, Nozari N, Herremans T, Kortbeek LM, Pinelli E. Evaluation and improvement of two PCR targets in molecular typing of clinical samples of Leishmania patients. Exp Parasitol. 2011;127(1):36-41. doi: 10.1016/j.exppara.2010.06.024. 
20.Gasser RB, Stevenson LA, Chilton NB, Nansen P, Bucknell DG, Beveridge I. Species markers for equine strongyles detected in intergenic rDNA by PCR-RFLP. Mol Cell Probes. 1996;10(5):371-8. doi: 10.1006/mcpr.1996.0050. 
21.Chargui N, Bastien P, Kallel K, Haouas N, Akrout FM, Masmoudi A, et al. Usefulness of PCR in the diagnosis of cutaneous leishmaniasis in Tunisia. Trans R Soc Trop Med Hyg. 2005;99(10):762-8. doi: 10.1016/j.trstmh.2005.06.002. 
22.Jirku M, Zemanova E, Al-Jawabreh A, Schonian G, Lukes J. Development of a direct species-specific PCR assay for differential diagnosis of Leishmania tropica. Diagn Microbiol Infect Dis. 2006;55(1):75-9. doi: 10.1016/j. diagmicrobio.2005.12.001. 
23.Behravan MR, Moin-Vaziri V, Haghighi A, Rahbarian N, Taghipour N, Abadi A, et al. Molecular identification of Leishmania species in a re-emerged focus of cutaneous leishmaniasis in Varamin district, Iran. J Arthropod Borne Dis. 2017;11(1):124-31. 
24.Eslami G, Anvarii H, Ebadi M, Nabipour Y, Mirzaei F, Gholamrezaei M, et al. The changing profile of cutaneous leishmaniasis agent in a central province of Iran. Tanzan J Health Res. 2013;15(1):33-9. 
25.El-Beshbishy HA, Al-Ali KH, El-Badry AA. Molecular characterization of cutaneous leishmaniasis in Al-Madinah AlMunawarah province, western Saudi Arabia. Int J Infect Dis. 2013;17(5):e334-8. doi: 10.1016/j.ijid.2012.11.015. 
26.Al-Nahhas SA, Kaldas RM. Characterization of Leishmania species isolated from cutaneous human samples from central region of Syria by RFLP analysis. ISRN Parasitol. 2013;2013:308726. doi: 10.5402/2013/308726. 
27.Marfurt J, Nasereddin A, Niederwieser I, Jaffe CL, Beck HP, Felger I. Identification and differentiation of Leishmania species in clinical samples by PCR amplification of the miniexon sequence and subsequent restriction fragment length polymorphism analysis. J Clin Microbiol. 2003;41(7):3147-53.